US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.800
  • -0.060-3.23%
Close Dec 27 16:00 ET
  • 1.810
  • +0.010+0.56%
Post 19:55 ET
83.84MMarket Cap-1.67P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Reviva Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Reviva Pharmaceuticals Earnings Reports

  • 8-K: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 14 17:31 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 14 17:21 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 08:19 ET

  • 8-K: Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 14 08:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 23, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data